MONTREAL, Nov. 17, 2016 -- Ropack Pharma Solutions announces it will launch an international serialization hub as a practical solution for pharmaceutical organizations and contract packaging partners that are not serialization-ready by the Drug Supply Chain Security Act (DSCSA) mandated deadline.
Through the serialization hub, packaged pharmaceutical products are sent by an organization’s in-house packaging team or contract partners to Ropack’s Montreal facility. There the packaged products are serialized as required – to the product, the carton or the palette. The serialized product is then shipped, as directed, to a distribution network in the U.S. or Canada, a warehouse for aggregation with other orders or to international destinations which have already adopted serialization.
“Our serialization hub is an efficient alternative,” notes Paul Dupont, Ropack’s VP of Marketing and Business Development. “Becoming serialization-ready is a complex, time-consuming and expensive undertaking which is not practical for every company.” Dupont points out that his company’s serialization hub reduces an organization’s capital expenditures, need for increased personnel and the multifaceted coordination serialization requires.
“A significant benefit is that pharma companies can continue to use their trusted contract packagers – or in-house team – then outsource the serialization component to Ropack.”
According to Dupont, an added benefit is that international shipping from Canada is significantly easier than from the U.S.
Ropack Pharma Solutions (RPS) brings solid oral dosage packaging solutions to leading pharmaceutical and natural health organizations: bottle, flip-top vial, blister (cold formed and thermoformed), stick-packs, sachets, strip-packs. RPS's International Serialization Hub will provide a practical solution for organizations not serialization-ready by November 2017. Headquartered in Montreal, RPS offers the highest level of quality along with gold-standard technology and a responsive, cross-trained staff. Since 1976.
Contact: Paul Dupont, VP Marketing and Business Development Ropack, Inc. [email protected] 513.846.0921


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



